Improved killing of HIV-infected cells by a combination of three antibodies: implications for clearing persistent infection

• M. Tuyishime,
• C. Garrido,
• S. Jha,
• D. Mielke,
• M. Moeser,
• B. Haynes,
• S. Joseph,
• D. Margolis,
• G. Ferrari

Affiliations

M. Tuyishime

Department of Surgery, Duke University Medical Center, Durham, USA

C. Garrido

UNC HIV Cure Center and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA

S. Jha

Department of Surgery, Duke University Medical Center, Durham, USA

D. Mielke

Department of Surgery, Duke University Medical Center, Durham, USA

M. Moeser

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA

B. Haynes

Duke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, USA

S. Joseph

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA

D. Margolis

Departments of Microbiology and Immunology, and Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA

G. Ferrari

Department of Surgery, Duke University Medical Center, Durham, USA